$100 Oil and a Rate-Hike Bet Overshadow Friday's Bounce

US stocks closed higher on Friday, Sept. 11, 2026, with the S&P 500 ETF at $764.29 (+0.85%), the Nasdaq 100 ETF at $714.88 (+0.87%) and the Dow ETF at $525.79 (+0.97%), but the week was a losing one as $100 oil and surging Treasury yields left traders positioning for a Federal Reserve rate hike.

The final session of the week went the bulls' way, and it still was not enough. The SPDR S&P 500 ETF (NYSEARCA: SPY) closed at $764.29, up 0.85% from the prior close of $757.83. The Invesco QQQ Trust (NASDAQ: QQQ), which tracks the Nasdaq 100, finished at $714.88, up 0.87% from $708.69. The SPDR Dow Jones Industrial Average ETF (NYSEARCA: DIA) ended at $525.79, a 0.97% gain from $520.75. All figures are as of the last trade at 20:00 GMT on Friday, Sept. 11, 2026.

Set against the week as a whole, those are consolation prizes. As Investor's Business Daily laid out heading into the futures session, the market spent the week absorbing two things it does not like at once: crude oil at the $100 mark and Treasury yields pushing higher. The combination has revived a question that had been parked for most of the year — whether the Federal Reserve's next move is a cut at all, or a hike.

Why $100 crude changes the arithmetic on rates

Oil at three figures is not, by itself, a monetary policy event. It becomes one when it lands on an inflation picture that the central bank already regards as unfinished. Energy costs feed through to headline inflation quickly and into transport, freight and packaged-goods prices more slowly, which is precisely the path that makes a rate-setting committee nervous about calling the job done.

That is the mechanism behind the surge in Treasury yields. When traders push out the timing of rate cuts — or begin pricing the opposite — the repricing shows up first in government bond yields. Higher yields raise the discount rate applied to future corporate profits, and the stocks most sensitive to that arithmetic are the long-duration growth names that have carried the indexes. It also raises the bar for equities in a more mundane way: the risk-free return an investor can lock in without owning a single share goes up.

The week's damage, in other words, was not about earnings. It was about the price of money and the price of a barrel moving in the same unhelpful direction at the same time.

Apple and Moderna set apart from the tape

Against that backdrop, IBD flagged Apple (AAPL) and Moderna (MRNA) as new buys — a designation that in that methodology means a stock has cleared a technical entry point on volume rather than a valuation judgment. Both closed Friday well ahead of the broad market.

Apple ended the session at 332.27, up 1.75% from the prior close of 326.57, after trading between 326.30 and 336.22. That is roughly double the S&P 500 ETF's move on the day, and Apple finished below its intraday high, which technical traders read as a stock that gave some ground into the close rather than one that ran away.

Moderna was the more dramatic of the two, closing at 143.97, up 5.38% from 136.62, with a day range of 135.01 to 149.73. That is a wide band — the stock traded on both sides of its previous close before settling in the upper half. A biotech moving more than five percent in a session that lifted the Nasdaq 100 by under one percent is not riding the index; something stock-specific is doing the work.

The pairing is itself worth noting. Apple is the largest-cap, most widely held name in the market, a stock that functions as a proxy for index risk. Moderna is a high-beta biotech whose price action is driven by pipeline and cash-burn expectations. Leadership appearing at both ends of that spectrum in the same week is a different picture from leadership concentrated in one sector, and it is one reason the tape has not simply rolled over despite the macro pressure.

How a hike, if it comes, would hit

Markets have spent an extended stretch trained to treat the next Fed move as a cut with only the timing in doubt. A genuine hike scenario reverses the reflexes built on that assumption. Rate-sensitive corners — housing-linked shares, small caps carrying floating-rate debt, speculative growth without near-term cash flow — carry the most exposure. Banks sit in a more ambiguous place, benefiting from wider spreads on new lending but facing mark-to-market pressure on securities portfolios and a slower loan pipeline.

For an investor holding Apple or Moderna here, the practical question is not whether the macro backdrop is friendly. It plainly is not. It is whether a position entered near a technical breakout has enough room above it to survive a broad-market drawdown triggered by yields. Breakouts attempted into a hostile tape have a higher failure rate than breakouts attempted into a rising one, which is why disciplined entry rules typically pair a buy point with a defined stop rather than a conviction argument.

The markers to watch next week

Three things will decide whether Friday's bounce extends or was a pause inside a decline.

• Crude. Whether oil holds the $100 handle or slips back below it is the single cleanest read on how much inflation pressure is actually in the pipeline. A retreat takes the most urgent argument for a hike off the table.
• The long end of the Treasury curve. Yields that keep climbing will cap equity rallies regardless of how good individual earnings look. Yields that stabilize give growth stocks room to work.
• Breadth. A one-day gain of under one percent across all three major index ETFs is a broad advance in direction but a modest one in magnitude. If the next leg up is carried by a shrinking group of names, the rally is thinner than the index level suggests.

The week's lesson is an old one, restated. A market can produce a perfectly respectable Friday and still finish lower over five sessions, because the forces setting the direction — the cost of energy and the cost of borrowing — operate on a longer clock than any single session's flows. Until one of those two turns, the burden of proof stays with the buyers.

Key facts

• S&P 500 ETF (SPY): $764.29, +0.85%, as of 20:00 GMT Sept. 11, 2026
• Apple (AAPL): 332.27, +1.75%, day range 326.30–336.22 at the Sept. 11 close
• Moderna (MRNA): 143.97, +5.38%, day range 135.01–149.73 at the Sept. 11 close
• Macro pressure: Oil near $100 and surging Treasury yields, with a Fed rate hike seen as live

Frequently asked questions

Where did the major US indexes close on Sept. 11, 2026?

The SPDR S&P 500 ETF closed at $764.29, up 0.85% from a prior close of $757.83. The Invesco QQQ Trust, tracking the Nasdaq 100, ended at $714.88, up 0.87%. The SPDR Dow Jones Industrial Average ETF finished at $525.79, up 0.97%. All prices are as of the last trade at 20:00 GMT that day.

Why is a Fed rate hike back in the conversation?

Oil trading around $100 a barrel feeds directly into headline inflation and, with a lag, into freight and consumer goods prices. That has pushed Treasury yields higher as traders reprice the path of policy. When inflation pressure rebuilds, the case for cutting weakens and the possibility of a hike returns to the table.

How did Apple shares perform on Friday?

Apple closed at 332.27, a gain of 1.75% from the previous close of 326.57. The stock traded between 326.30 and 336.22 during the session, finishing below its intraday high. That advance was roughly double the move in the S&P 500 ETF on the same day.

What happened to Moderna stock?

Moderna closed at 143.97, up 5.38% from a prior close of 136.62. Its day range ran from 135.01 to 149.73, meaning the stock traded on both sides of its previous close before settling in the upper part of that band. The move far outpaced the Nasdaq 100's 0.87% gain.

What does it mean when a stock is called a 'new buy'?

In Investor's Business Daily's technical framework, a new buy means the stock has cleared a defined entry point — typically a chart pattern resolving upward on strong volume. It is a timing signal based on price and volume behavior, not a valuation verdict on the underlying business or a price target.

Why do rising Treasury yields hurt stock prices?

Higher yields raise the discount rate investors apply to future corporate earnings, which lowers the present value of those earnings. The effect is largest for growth companies whose profits sit far in the future. Rising yields also make government bonds a more competitive alternative to equities for the same money.

Sources

• Dow Jones Futures: $100 Oil, Surging Yields Pressure Stocks With Fed Rate Hike Seen. Apple, Moderna Are New Buys. — Investors Business Daily

Photo: Charles Criscuolo · Pexels Licence — source